Peter Stegagno - 14 Dec 2017 Form 4 Insider Report for SANUWAVE Health, Inc. (SNWV)

Role
Chief Operating Officer
Signature
/s/ Griffin D. Foster as Attorney-in-Fact for Peter Stegagno
Issuer symbol
SNWV
Transactions as of
14 Dec 2017
Net transactions value
+$0.2655
Form type
4
Filing time
07 Apr 2025, 16:07:12 UTC
Previous filing
07 Apr 2025
Next filing
09 Jun 2025
SEC
View on sec.gov

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction SNWV Common Stock Award +885 +14750% 891 29 Aug 2019 Direct F1
transaction SNWV Common Stock Award +1,141 +128% 2,032 29 Aug 2019 Direct F2

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction SNWV Class N Warrant (right to buy) Award $0.2655 +885 $0.000300 885 21 Dec 2017 Common Stock 885 $0.000300 Direct
transaction SNWV Class N Warrant (right to buy) Disposed to Issuer $0 -885 -100% $0.000000 0 23 Jan 2019 Common Stock 885 $0.000300 Direct F3
transaction SNWV Class N Warrant (right to buy) Award $0 +885 $0.000000 885 23 Jan 2019 Common Stock 885 $0.000300 Direct F3
transaction SNWV Class N Warrant (right to buy) Disposed to Issuer $0 -885 -100% $0.000000 0 01 May 2019 Common Stock 885 $0.000300 Direct F4
transaction SNWV Class N Warrant (right to buy) Award $0 +885 $0.000000 885 01 May 2019 Common Stock 885 $0.000300 Direct F4
transaction SNWV Class N Warrant (right to buy) Disposed to Issuer $0 -885 -100% $0.000000 0 31 May 2019 Common Stock 885 $0.000300 Direct F5
transaction SNWV Class N Warrant (right to buy) Award $0 +885 $0.000000 885 31 May 2019 Common Stock 885 $0.000300 Direct F5
transaction SNWV Class N Warrant (right to buy) Options Exercise $0 -885 -100% $0.000000 0 29 Aug 2019 Common Stock 885 $0.000300 Direct F1
transaction SNWV Class O Warrant (right to buy) Award $0 +1,141 $0.000000 1,141 11 Dec 2017 Common Stock 1,141 $0.000300 Direct F6
transaction SNWV Class O Warrant (right to buy) Disposed to Issuer $0 -1,141 -100% $0.000000 0 01 Mar 2019 Common Stock 1,141 $0.000300 Direct F7
transaction SNWV Class O Warrant (right to buy) Award $0 +1,141 $0.000000 1,141 01 Mar 2019 Common Stock 1,141 $0.000300 Direct F7
transaction SNWV Class O Warrant (right to buy) Disposed to Issuer $0 -1,141 -100% $0.000000 0 31 May 2019 Common Stock 1,141 $0.000300 Direct F8
transaction SNWV Class O Warrant (right to buy) Award $0 +1,141 $0.000000 1,141 31 May 2019 Common Stock 1,141 $0.000300 Direct F8
transaction SNWV Class O Warrant (right to buy) Options Exercise $0 -1,141 -100% $0.000000 0 29 Aug 2019 Common Stock 1,141 $0.000300 Direct F2
transaction SNWV Stock Option (right to buy) Award $0 +1,333 $0.000000 1,333 16 Jun 2016 Common Stock 1,333 $15.00 Direct F9
transaction SNWV Stock Option (right to buy) Award $0 +1,132 $0.000000 1,132 09 Nov 2016 Common Stock 1,132 $67.50 Direct F9
transaction SNWV Stock Option (right to buy) Award $0 +1,600 $0.000000 1,600 15 Jun 2017 Common Stock 1,600 $41.25 Direct F9
transaction SNWV Stock Option (right to buy) Award $0 +2,000 $0.000000 2,000 20 Sep 2018 Common Stock 2,000 $78.75 Direct F9
transaction SNWV Stock Option (right to buy) Award $0 +133 $0.000000 133 26 Aug 2019 Common Stock 133 $56.25 Direct F9
transaction SNWV Stock Option (right to buy) Award $0 +40,000 $0.000000 40,000 22 Oct 2024 Common Stock 40,000 $14.20 Direct F10
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 On August 29, 2019, the reporting person exercised the Class N Warrants for 885 shares of common stock of Sanuwave Health, Inc. (the "Company") at an exercise price of $0.00029 per share.
F2 On August 29, 2019, the reporting person exercised the Class O Warrants for 1,141 shares of the Company's common stock at an exercise price of $0.00029 per share.
F3 On January 23, 2019, the Company extended the expiration date of the Class N Warrants to May 1, 2019.
F4 On May 1, 2019, the Company extended the expiration date of the Class N Warrants to June 28, 2019.
F5 On May 31, 2019, the Company extended the expiration date of the Class N Warrants to September 3, 2019.
F6 On December 11, 2017, the reporting person received Class O Warrants exercisable for 1,141 shares of common stock at an exercise price of $0.00029 per share as compensation.
F7 On March 1, 2019, the Company extended the expiration date of the Class O Warrants to June 28, 2019.
F8 On May 31, 2019, the Company extended the expiration date of the Class O Warrants to September 3, 2019.
F9 Options were fully vested at the grant date.
F10 Options will vest over a period of three years in 12 equal installments on each quarterly anniversary of the grant date.

Remarks:

All share amounts and exercise prices herein have been retroactively adjusted to reflect the 1-for-375 reverse stock split of the Company's common stock which occurred on October 18, 2024.